SCHEMBL3428907

SCHEMBL3428907

O=C(Oc1[c]cccc1)c1ccccc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.56
HSD17B10 Q99714 4/20 0.56
ALOX15 P16050 1/20 0.56
KDM4E B2RXH2 6/20 0.51
ALDH1A1 P00352 5/20 0.51
TSHR P16473 2/20 0.50
LMNA P02545 2/20 0.50
TDP1 Q9NUW8 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
HMGB1 P09429 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
CA14 Q9ULX7 1/20 0.42
MAPT P10636 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3428268 0.86 ESR1 (0.43) HPGDHSD17B10ALOX15KDM4EALDH1A1
SCHEMBL24725 0.81 KMT2A (0.48) HPGDHSD17B10ALOX15KDM4EALDH1A1
SCHEMBL23289 0.77 F2 (0.48) HSD17B10ALOX15ALDH1A1TSHRLMNA
SCHEMBL3231544 0.77 F2 (0.30) LMNA
SCHEMBL8585925 0.76 KMT2A (0.52) KDM4EALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL9620982 0.76 SLC6A3 (0.59) HPGDHSD17B10ALOX15KDM4EALDH1A1
SCHEMBL8226022 0.74 CYP3A4 (0.40) HSD17B10KDM4EALDH1A1TSHRLMNA
SCHEMBL7614991 0.74 HPGD (0.88) HPGDHSD17B10ALOX15KDM4EALDH1A1
SCHEMBL7261346 0.74 L3MBTL1 (0.35) HPGDHSD17B10ALOX15ALDH1A1TSHR
Phenyl Salicylate SCHEMBL2519840 0.72 HPGD (1.00) HPGDHSD17B10ALOX15KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836592-A1 AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1998-04-22 EP claimed
WO-1997002249-A1 NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1997-01-23 WO claimed
WO-2010146351-A1 INDOLYLMETHYL-MORPHOLINE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2010-12-23 WO disclosed
US-6136969-A PROTEIN KINASE INHIBITORS; 4-HYDROXYBENZOIC ACID 3-(4-(4-FLUOROBENZOYLOXY)-BENZOYLAMINO)-AZEPAN-4-YL ESTER HOFFMANN-LA ROCHE INC. (US) 2000-10-24 US disclosed
US-5907038-A PROTEIN KINASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1999-05-25 US disclosed
EP-0836592-A1 AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1998-04-22 EP disclosed
WO-1997002249-A1 NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1997-01-23 WO disclosed